Cargando…

WHO IS AT RISK FOR CARDIOMYOPATHY IN COVID 19

Detalles Bibliográficos
Autores principales:	Daftari, Diana, Savoj, Javad, Skaf, George, Gelman, Samantha, Aytyanont, Napatkamon, Heineke, Hyunju, Biswas, Mimi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091243/ http://dx.doi.org/10.1016/S0735-1097(21)04389-8

Ejemplares similares

ANALYSIS OF MYOCARDIAL INFARCTION AND MYOCARDIAL INFARCTION COMPLICATIONS BEFORE AND DURING COVID-19 PANDEMIC FROM MULTIPLE HOSPITALS
por: To, Magnus, et al.
Publicado: (2022)

OUTCOMES OF PATIENTS WITH PULMONARY EMBOLISM WITH HISTORY OF COVID-19 ARE AS POOR AS PATIENTS WITH PULMONARY EMBOLISM WITH SEVERE COVID-19
por: Ho, Timothy D., et al.
Publicado: (2022)

RIGHT VENTRICULAR DYSFUNCTION/ENLARGEMENT AS A PROGNOSTIC MARKER FOR MORTALITY IN PATIENTS WITH COVID-19 INFECTION
por: Madkour, Muhammad, et al.
Publicado: (2021)

STRESS-INDUCED CARDIOMYOPATHY IN A PANDEMIC YEAR
por: Cundiff, Michael, et al.
Publicado: (2021)

RISK PREDICTORS FOR MYOCARDIAL INJURY IN SEVERE COVID-19
por: Nascimento, Jorge H.P., et al.
Publicado: (2021)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION
por: Gurbel, Paul A., et al.
Publicado: (2021)

IMPACT OF THROMBOPROPHYLACTIC STRATEGY ON BLEEDING RISK AMONG IN- AND OUTPATIENTS WITH COVID-19
por: Svet, Mark, et al.
Publicado: (2021)

IS HYPERTENSION (HTN) AN INDEPENDENT RISK FACTOR FOR MORTALITY IN COVID-19 PATIENTS?
por: Mughal, Mohsin, et al.
Publicado: (2021)

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

COVID-19 VACCINES AND ATRIAL FIBRILLATION RISK: A PHARMACOVIGILANCE ANALYSIS
por: Kattubadi, Ayeesha, et al.
Publicado: (2022)

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES
por: Arif, Yousif, et al.
Publicado: (2022)

PREDICTING COVID-19 INPATIENT MORTALITY AND MORBIDITY BY USING CARDIOVASCULAR RISK SCORES
por: Ahmed, Eyad, et al.
Publicado: (2021)

PERFORMANCE OF CURRENT THROMBOEMBOLISM RISK ASSESSMENT TOOLS IN PATIENTS WITH SEVERE COVID-19
por: Rios, Luis H. Paz, et al.
Publicado: (2021)

FORMER INCARCERATION AS A RISK FACTOR FOR COVID-19 ASSOCIATED SUDDEN DEATH
por: Raghunathan, Sahana, et al.
Publicado: (2022)

SOLUBLE P-SELECTIN, PLATELET ACTIVITY AND RISK OF MORBIDITY AND MORTALITY IN COVID-19
por: Mosarla, Ramya, et al.
Publicado: (2022)

OUTCOMES AND READMISSION RISK OF CRITICALLY ILL COVID-19 PATIENTS WITH CARDIOVASCULAR OUTCOMES
por: Manjappachar, Nirmala, et al.
Publicado: (2022)

HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19
por: De Michieli, Laura, et al.
Publicado: (2021)

RISK OF RECURRENT MYOCARDITIS FOLLOWING COVID-19 MRNA VACCINATION IN ADULTS WITH PRIOR HISTORY
por: Simone, Anthony, et al.
Publicado: (2022)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

UTILITY OF AN AUTOMATED ARTIFICIAL INTELLIGENCE ECHOCARDIOGRAPHY SOFTWARE IN RISK STRATIFICATION OF HOSPITALIZED COVID-19 PATIENTS
por: Wang, Tom Kai Ming, et al.
Publicado: (2021)

RISK FACTORS OF ARTERIAL THROMBOEMBOLISM IN HOSPITALIZED COVID-19 PATIENTS: A MULTICENTER COHORT STUDY
por: Lee, Yi, et al.
Publicado: (2022)

SERUM BIOMARKERS IN MORTALITY RISK STRATIFICATION IN PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA IN EARLY AND REMOTE PERIOD
por: Zagidullin, Naufal, et al.
Publicado: (2022)

COVID-19 RISK PERCEPTION AND IDENTIFICATION OF APPROPRIATE MITIGATION STRATEGIES AMONG ADULTS WITH CONGENITAL HEART DEFECTS
por: Jackson, Jamie, et al.
Publicado: (2022)

RISK OF CARDIOVASCULAR COMPLICATIONS IN ETHNIC MINORITIES INFECTED WITH COVID-19 - EXPERIENCE IN A MID-SIZED MIDWESTERN CITY
por: Desai, Viral, et al.
Publicado: (2021)

DO ELECTIVE CARDIAC PROCEDURES INCREASE THE RISK OF SYMPTOMATIC COVID-19 TRANSMISSION WITH CURRENT HOSPITAL PRECAUTIONARY MEASURES?
por: Suhotliv, Amy, et al.
Publicado: (2021)

ECHOCARDIOGRAPHIC ABNORMALITIES ARE COMMON AMONG PATIENTS WITH COVID-19 INFECTION AND INDEPENDENTLY CONFER INCREASED RISK OF IN-HOSPITAL MORTALITY
por: Homan, Edwin A., et al.
Publicado: (2021)

D-DIMER TRENDS IN PATIENTS HOSPITALIZED WITH COVID-19: PATTERNS AND IN-HOSPITAL PROGNOSTIC SIGNIFICANCE
por: Ronderos, Diana, et al.
Publicado: (2021)

RISK FACTORS ASSOCIATED WITH ICU ADMISSION AND DEATH AMONG COVID-19 PATIENTS IN A LARGE ACADEMIC HEALTHCARE NETWORK
por: Meena, Richard, et al.
Publicado: (2021)

RISK FACTORS FOR COVID-19 RELATED MORTALITY- A SYSTEMATIC REVIEW AND META-ANALYSIS OF 26 STUDIES AND 9690 PATIENTS
por: Goel, Sunny, et al.
Publicado: (2021)

RETURN TO PLAY EVALUATION POST COVID - LONGITUDINAL EXPERIENCE IN CARDIAC RISK ASSESSMENT AT A DIVISION I ATHLETIC PROGRAM
por: Sivalokanathan, Sanjay, et al.
Publicado: (2023)

ECHOCARDIOGRAPHY DERIVED PREDICTORS OF WORSE OUTCOMES IN THE ACUTE PHASE OF COVID-19 PATIENTS COMPARED TO MATCHED CONTROLS
por: Omar, Alaa, et al.
Publicado: (2021)

OSBORNE WAVE IN ECG AS A PREDICTOR OF HOSPITAL MORTALITY IN COVID-19 ASSOCIATED PNEUMONIA
por: Zagidullin, Naufal, et al.
Publicado: (2021)

IMAGING AND METABOLIC STRESS FINDINGS IN COLLEGE ATHLETES RECOVERING FROM COVID-19 INFECTION
por: Ullah, Muhammad Wajih, et al.
Publicado: (2022)

HEALTH DISPARITIES INVOLVING HOSPITALIZATIONS AMONG COVID-19 VACCINATED CARDIOVASCULAR DISEASE PATIENTS INFECTED BY SARS-COV-2
por: Khodaverdi, M., et al.
Publicado: (2022)

NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
por: Annie, Frank H., et al.
Publicado: (2021)

TIME SINCE LAST CHEMOTHERAPY AND COVID-19 OUTCOMES IN CARDIO-ONCOLOGY INPATIENTS
por: Visaria, Aayush, et al.
Publicado: (2022)

COVID-19 RELATED OUTCOMES IN PATIENTS WITH PREEXISTING CARDIOVASCULAR DISEASES, WITH OR WITHOUT CANCER
por: Patel, Brijesh D., et al.
Publicado: (2022)

HEMATOLOGICAL ABNORMALITIES IN CARDIOVASCULAR AND CARDIO-ONCOLOGY PATIENTS ARE ASSOCIATED WITH WORSE COVID-19 OUTCOMES
por: Visaria, Aayush, et al.
Publicado: (2022)

RELATIONSHIP BETWEEN PARAMETERS OF RIGHT VENTRICULAR HEMODYNAMICS TO OUTCOMES IN COVID-19: CLINICAL AND ECHOCARDIOGRAPHIC COMPARISONS BETWEEN THE FIRST AND SECOND WAVES OF THE PANDEMIC
por: Hernandez, Nolberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_llq0fup6b8vvu1s2150b5n6kak